1. Home
  2. MDAIW vs OGN Comparison

MDAIW vs OGN Comparison

Compare MDAIW & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDAIW

Spectral AI Inc.

HOLD

Current Price

$0.50

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.16

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDAIW
OGN
Founded
N/A
1923
Country
United States
United States
Employees
78
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MDAIW
OGN
Price
$0.50
$7.16
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$14.10
AVG Volume (30 Days)
35.6K
4.8M
Earning Date
02-27-2025
11-10-2025
Dividend Yield
N/A
1.11%
EPS Growth
N/A
N/A
EPS
N/A
1.91
Revenue
$27,264,000.00
$6,301,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.75
Revenue Growth
44.52
N/A
52 Week Low
$0.08
$6.18
52 Week High
$0.90
$17.23

Technical Indicators

Market Signals
Indicator
MDAIW
OGN
Relative Strength Index (RSI) 48.02 43.82
Support Level $0.45 $6.90
Resistance Level $0.60 $7.49
Average True Range (ATR) 0.07 0.30
MACD 0.02 0.03
Stochastic Oscillator 59.21 25.65

Price Performance

Historical Comparison
MDAIW
OGN

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: